Financial and geographic disparities contributing to elevated risk for heart disease are explored.
This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD. The panel discusses socioeconomic factors impacting heart failure risk. Wright highlights social determinants like economic and income insecurity, food insecurity, transportation challenges, education levels, lived experiences, and psychosocial stress. Wright also highlights Individuals with lower incomes have higher cardiovascular disease risk due to increased stress hormones like catecholamines and cortisol. A person’s zip code might better predict their health than genetics.
Albert expands on the patient impact, explaining how limited income can reduce access to medications, transportation, and proper nutrition. Patients may live in food deserts without access to healthy options. Many are on fixed incomes and Medicare or Medicaid and cannot easily afford new treatments. Readmissions also financially penalize hospitals, influencing their care approaches to reduce overall readmission rates. The scope of heart failure is expanding, affecting more patients nationwide. In summary, this multifactorial disease has significant individual and societal impacts that require urgent attention.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Gene Therapy Enhances Visual Processing for Inherited Retinal Disease
December 3rd 2024Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.
Read More
New Guidelines Clarify EORTC Quality of Life Scores for Chronic Lymphocytic Leukemia
December 2nd 2024Meaningful change thresholds for the EORTC Quality of Life Questionnaire in chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are: −11/+11 for symptom burden, −16/+16 for physical condition/fatigue, and −16/+13 for worries/fears.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS
November 29th 2024The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated with disability worsening despite not relapsing—known as progression independent of relapse activity.
Read More